vs
IGC Pharma, Inc.（IGC）与Rafael Holdings, Inc.（RFL）财务数据对比。点击上方公司名可切换其他公司
Rafael Holdings, Inc.的季度营收约是IGC Pharma, Inc.的1.3倍（$240.0K vs $191.0K），IGC Pharma, Inc.净利率更高（-953.4% vs -4090.0%，领先3136.6%），Rafael Holdings, Inc.同比增速更快（87.5% vs -53.6%），过去两年Rafael Holdings, Inc.的营收复合增速更高（85.2% vs -19.0%）
IGC制药是一家处于临床阶段的生物制药企业，专注于研发及商业化大麻素衍生的创新治疗药物，核心管线覆盖神经退行性疾病、疼痛管理及罕见病治疗领域，主要市场位于北美，正推进全球新兴医疗市场布局。
拉斐尔先进防御系统有限公司是一家以色列国防科技企业，其前身是以色列国防部旗下负责开发武器与军用技术的国家级国防研发实验室，2002年正式改组为有限公司，专注于各类先进国防装备与军事技术的研发生产。
IGC vs RFL — 直观对比
营收规模更大
RFL
是对方的1.3倍
$191.0K
营收增速更快
RFL
高出141.1%
-53.6%
净利率更高
IGC
高出3136.6%
-4090.0%
两年增速更快
RFL
近两年复合增速
-19.0%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $191.0K | $240.0K |
| 净利润 | $-1.8M | $-9.8M |
| 毛利率 | 51.8% | — |
| 营业利润率 | -1517.8% | -4225.4% |
| 净利率 | -953.4% | -4090.0% |
| 营收同比 | -53.6% | 87.5% |
| 净利润同比 | -6.1% | -9.0% |
| 每股收益（稀释后） | $-0.02 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IGCRFL
| Q4 25 | — | $240.0K | ||
| Q3 25 | $191.0K | — | ||
| Q2 25 | $328.0K | — | ||
| Q4 24 | $257.0K | — | ||
| Q3 24 | $412.0K | $165.0K | ||
| Q2 24 | $272.0K | $336.0K | ||
| Q1 24 | $295.0K | $68.0K | ||
| Q4 23 | $204.0K | $68.0K |
净利润IGCRFL
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.6M | — | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $-1.7M | $-4.5M | ||
| Q2 24 | $-2.4M | $-32.4M | ||
| Q1 24 | $-2.9M | $6.0M | ||
| Q4 23 | $-5.6M | $-3.6M |
毛利率IGCRFL
| Q4 25 | — | — | ||
| Q3 25 | 51.8% | — | ||
| Q2 25 | 47.0% | — | ||
| Q4 24 | 40.5% | — | ||
| Q3 24 | 48.1% | — | ||
| Q2 24 | 59.9% | 74.7% | ||
| Q1 24 | 58.0% | — | ||
| Q4 23 | 65.2% | — |
营业利润率IGCRFL
| Q4 25 | — | -4225.4% | ||
| Q3 25 | -1517.8% | — | ||
| Q2 25 | -580.8% | — | ||
| Q4 24 | -730.7% | — | ||
| Q3 24 | -427.2% | -2330.3% | ||
| Q2 24 | -880.9% | -27726.5% | ||
| Q1 24 | -735.6% | -4622.1% | ||
| Q4 23 | -1469.6% | -3644.1% |
净利率IGCRFL
| Q4 25 | — | -4090.0% | ||
| Q3 25 | -953.4% | — | ||
| Q2 25 | -487.5% | — | ||
| Q4 24 | -711.7% | — | ||
| Q3 24 | -416.7% | -2707.9% | ||
| Q2 24 | -874.3% | -9628.3% | ||
| Q1 24 | -978.0% | 8892.6% | ||
| Q4 23 | -2739.7% | -5350.0% |
每股收益（稀释后）IGCRFL
| Q4 25 | — | $-0.19 | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $-0.02 | $-0.19 | ||
| Q2 24 | $-0.03 | $-1.36 | ||
| Q1 24 | — | $0.25 | ||
| Q4 23 | $-0.09 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $45.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.1M | $85.2M |
| 总资产 | $9.7M | $105.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IGCRFL
| Q4 25 | — | $45.5M | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $454.0K | — | ||
| Q4 24 | $470.0K | — | ||
| Q3 24 | $1.5M | $2.7M | ||
| Q2 24 | $1.8M | $7.4M | ||
| Q1 24 | $1.2M | $7.1M | ||
| Q4 23 | $1.4M | $13.2M |
股东权益IGCRFL
| Q4 25 | — | $85.2M | ||
| Q3 25 | $8.1M | — | ||
| Q2 25 | $6.1M | — | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $7.4M | $82.2M | ||
| Q2 24 | $7.9M | $86.1M | ||
| Q1 24 | — | $104.9M | ||
| Q4 23 | $9.1M | $98.2M |
总资产IGCRFL
| Q4 25 | — | $105.4M | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $7.9M | — | ||
| Q4 24 | $9.1M | — | ||
| Q3 24 | $10.4M | $96.8M | ||
| Q2 24 | $10.6M | $101.6M | ||
| Q1 24 | $9.9M | $106.1M | ||
| Q4 23 | $11.3M | $95.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.1M | $-6.8M |
| 自由现金流经营现金流 - 资本支出 | $-2.1M | — |
| 自由现金流率自由现金流/营收 | -1109.4% | — |
| 资本支出强度资本支出/营收 | 15.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IGCRFL
| Q4 25 | — | $-6.8M | ||
| Q3 25 | $-2.1M | — | ||
| Q2 25 | $-1.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-996.0K | $-2.9M | ||
| Q2 24 | $-1.8M | $-251.0K | ||
| Q1 24 | $-526.0K | $-2.5M | ||
| Q4 23 | $-1.6M | $-2.1M |
自由现金流IGCRFL
| Q4 25 | — | — | ||
| Q3 25 | $-2.1M | — | ||
| Q2 25 | $-1.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.0M | — | ||
| Q2 24 | $-1.8M | $-375.0K | ||
| Q1 24 | $-541.0K | — | ||
| Q4 23 | $-1.7M | — |
自由现金流率IGCRFL
| Q4 25 | — | — | ||
| Q3 25 | -1109.4% | — | ||
| Q2 25 | -431.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -248.8% | — | ||
| Q2 24 | -658.1% | -111.6% | ||
| Q1 24 | -183.4% | — | ||
| Q4 23 | -811.3% | — |
资本支出强度IGCRFL
| Q4 25 | — | — | ||
| Q3 25 | 15.2% | — | ||
| Q2 25 | 2.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 14.0% | 36.9% | ||
| Q1 24 | 5.1% | — | ||
| Q4 23 | 33.3% | — |
现金转化率IGCRFL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.42× | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
